The risk of myocardial infarction is enchanced by a synergistic interaction between serum insulin and smoking

European Journal of Endocrinology

Volumn 147, Issue 5, 2002, Pages 641-647

  Bennet, Anna M ^a   Brismar, Kerstin ^b   Hallqvist, Johan ^b   Reuterwall, Christina ^b   de Faire, Ulf ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEART INFARCTION; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMOBILIZATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN INTERACTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SMOKING;

EID: 0036856211     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470641     Document Type: Article

References (23)

1. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR & Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980 19 205-210.
2. Welborn TA & Wearne K. Coronary heart disease and cardio-vascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979 2 154-160.
3. Fuller JH, Shipley MJ, Rose G, Jarrett JR & Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. British Medical Journal 1983 287 867-870.
4. Pyörälä K, Savolainen E, Kaukola S & Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki policemen study population. Acta Medica Scandinavica 1985 701 (Suppl) 38-52.
5. DeFronzo RA & Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991 14 173-193.
6. Lemne C & Brismar K. Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome - a study in borderline hypertension. Blood Pressure 1998 7 89-92.
7. Mogul HR, Marshall M, Frey M, Burke HB, Wynn PS, Wilker S et al. Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. Journal of Clinical Endocrinology and Metabolism 1996 81 4492-4495.
8. Reuterwall C, Hallqvist J, Ahlbom A, de Faire U, Diderichsen F, Hogstedt C et al. Higher relative but lower absolute risk of myocardial infarction in women than in men for some major risk factors in the SHEEP study. Journal of Internal Medicine 1999 246 161-174.
9. Stockholm County Council Report. Hjärtintensivvård. Behandlingsprogram för Danderyds sjukhus, Ersta sjukhus, Huddinge sjukhus, karolinska sjukhuset, Löwenströmska sjukhuset, Nacka sjukhus, Norrtälje sjukhus, Sabbatsbergs sjukhus, St Görans sjukhus, Södersjukhuset, Södertälje sjukhus. (Heart intensive care, Guidelines for treatment for Danderyd hospital, Ersta hospital etc. Stockhohm County Council, Sweden (in Swedish)), 1990.
10. Póvoa G, Roovete A & Hall K. Crossreaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinologica 1984 107 563-570.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
12. Theorell T, Perski A, Åkerstedt T, Sigala F, Ahlberg-Hultén G, Svensson J et al. Changes in job strain in relation to changes in psychosocial state: a longitudinal study. Scandinavian Journal of Work and Environmental Health 1988 14 189-196.
13. Rothman KJ & Greenland S. Modern Epidemiology, edn 2, ch 18, pp 329-342. Philadelphia: Lippincott-Raven, 1998.
14. Ruotolo G, Båvenholm P, Brismar K, Efendic S, Ericsson C-G, de Faire U et al. Serum insulin-like growth factor-1 level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. Journal of the American College of Cardiology 2000 35 647-654.
15. Söderberg S, Ahrén B, Eliasson M, Dinesen B, Brismar K & Olsson T. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women. European Journal of Endocrinology 2001 144 283-290.
16. Jarrett RJ, McCartney P & Keen H. The Bedford study: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982 22 79-84.
17. Attvall S, Fowelin J, Lager I, Von Shenck H & Smith U. Smoking induces insulin resistance - a potenital link with the insulin resistance syndome. Journal of Internal Medicine 1993 233 327-332.
18. Eliasson B, Taskinen M-R & Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996 94 878-881.
19. Hamsten A, Wiman B, de Faire U & Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New England Journal of Medicine 1985 313 1557-1563.
20. Hamsten A, Walldius G, Dahlén G, Johansson B & de Faire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 1986 59 223-235.
21. Fernqvist-Forbes E, Hilding A, Ekberg K & Brismar K. Influence of circulating epinephrine on insulin-like growth factor binding protein-1 in humans. Journal of Clinical Endocrinology and Metabolism 1997 82 2677-2680.
22. Reneland R, Alvarez E, Andersson PE, Haenni A, Byberg L & Lithell H. Induction of insulin resistance by beta-blockade but not ACE inhibition: long term treatment with atenolol or trandolapril. Journal of Human Hypertension 2000 14 175-180.
23. Julios S, Majahalme S & Palatini P. Antihypertensive treatment of patients with diabetes and hypertension. American Journal of Hypertension 2001 14 310S-316S.